The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment of metastatic colorectal cancer (mCRC) according to age.
 
Laura Ortega
No Relationships to Disclose
 
Gabriela Torres Pérez-Solero
No Relationships to Disclose
 
Marta Arregui Valles
No Relationships to Disclose
 
Manuel Alva Bianchi
No Relationships to Disclose
 
Inmaculada Aparicio Salcedo
No Relationships to Disclose
 
Gonzalo García González
No Relationships to Disclose
 
Iria Gallego Gallego
No Relationships to Disclose
 
Andres J. Muñoz Martín
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb/Pfizer; Bristol-Myers Squibb/Pfizer; Bristol-Myers Squibb/Pfizer; Bristol-Myers Squibb/Pfizer; Celgene; Celgene; Celgene; Celgene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Halozyme; Halozyme; Halozyme; Halozyme; LEO Pharma; LEO Pharma; LEO Pharma; LEO Pharma; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - Rovi; Rovi; Rovi; Rovi
Research Funding - LEO Pharma; LEO Pharma; LEO Pharma; LEO Pharma; Sanofi; Sanofi; Sanofi; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients; Risk assessment model in venous thromboembolism in cancer patients; Risk assessment model in venous thromboembolism in cancer patients; Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
 
Aitana Calvo Ferrándiz
No Relationships to Disclose
 
Montserrat Blanco-Codesido
No Relationships to Disclose
 
Miguel Martin
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; PharmaMar; PharmaMar; PharmaMar; PharmaMar; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Travel, Accommodations, Expenses - Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche